Gemcitabine and Effexor drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Gemcitabine (gemcitabine) and Effexor (venlafaxine hydrochloride). Common drug interactions include urinary tract infection among females and dyspnoea among males.

The phase IV clinical study analyzes what interactions people have when they take Gemcitabine and Effexor. It is created by eHealthMe based on reports of 72 people who take the same drugs from the FDA, and is updated regularly.

What is Gemcitabine?

Gemcitabine has active ingredients of gemcitabine. eHealthMe is studying from 31,337 Gemcitabine users. Check the latest studies of Gemcitabine.

What is Effexor?

Effexor has active ingredients of venlafaxine hydrochloride. It is often used in depression. eHealthMe is studying from 99,493 Effexor users. Check the latest studies of Effexor.

On Jul, 15, 2026

72 people who take Gemcitabine and Effexor together, and have interactions are studied.

Gemcitabine and Effexor drug interactions.

What are the common drug interactions of Gemcitabine and Effexor, by gender? *:

female:

Urinary tract infection
Hypoaesthesia (reduced sense of touch or sensation)
Impaired healing
Osteoarthritis (a joint disease caused by cartilage loss in a joint)
Night sweats (sweating in night)
Osteitis (a general term for inflammation of bone)
Rectal haemorrhage (bleeding from anus)
Staphylococcal infection (an infection with staphylococcus bacteria)
Arteriosclerosis (thickening and hardening of arteries)
Headache (pain in head)

male:

Dyspnoea (difficult or laboured respiration)
Bone marrow failure
Dehydration (dryness resulting from the removal of water)
Haemoglobin decreased
Urinary tract infection
Cholestasis (a condition where bile cannot flow from the liver to the duodenum)
Renal failure acute (rapid kidney dysfunction)
Tumour lysis syndrome (a group of metabolic complications that can occur after treatment of cancer, these complications are caused by the breakdown products of dying cancer cells)
Adenocarcinoma (malignant tumour formed from glandular structures in epithelial tissue)
Adnexa uteri cyst (ovarian cysts)

What are the common drug interactions of Gemcitabine and Effexor, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

Abdominal mass (localized enlargement or swelling in the human abdomen)
Abdominal pain
Abdominal pain upper
Actinomycosis (infection that causes sores, or abscesses)
Albumin globulin ratio decreased
Alopecia (absence of hair from areas of the body)
Alveolitis (inflammation in the socket of a tooth)
Amnesia (deficit in memory caused by brain damage, disease, or psychological trauma)
Anaemia (lack of blood)
Angina pectoris (chest pain due to ischemia of the heart muscle)

20-29:

n/a

30-39:

n/a

40-49:

Adenocarcinoma (malignant tumour formed from glandular structures in epithelial tissue)
Adnexa uteri cyst (ovarian cysts)
Adrenal carcinoma (malignant (cancer) cells form in the outer layer of the adrenal gland)
Anaemia (lack of blood)
Anhedonia (inability to experience pleasure from activities usually found enjoyable)
Atelectasis (partial or complete collapse of the lung)
Atrophic vulvovaginitis (inflammation of the vulva)
Breath sounds
Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
Cardiac failure congestive

50-59:

Pain
Spinal osteoarthritis (joint cartilage loss in spine)
Urinary tract infection
White blood cell count increased
Lumbar radiculopathy (radicular pain in the low back and legs)
Bone disorder
Bone pain
Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
Dizziness
Fatigue (feeling of tiredness)

60+:

Dyspnoea (difficult or laboured respiration)
Pain in extremity
Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection)
Arteriosclerosis (thickening and hardening of arteries)
Arthralgia (joint pain)
Arthritis (form of joint disorder that involves inflammation of one or more joints)
Arthropathy
Back pain
Bone atrophy (decrease in bone mass)
Breast cancer metastatic

What are the existing conditions these people have? *

Metastases To Bone (cancer spreads to bone): 21 people, 29.17%
Pain: 11 people, 15.28%
Insomnia (sleeplessness): 11 people, 15.28%
Breast Cancer Metastatic: 11 people, 15.28%
Breast Cancer: 11 people, 15.28%
Lung Cancer - Non-Small Cell (lung cancer): 10 people, 13.89%
Hypercalcaemia (elevated calcium (ca+) level in the blood): 10 people, 13.89%
Upper Respiratory Tract Infection: 9 people, 12.50%
Sleep Disorder: 9 people, 12.50%
Muscle Spasms (muscle contraction): 9 people, 12.50%

* Approximation only. Some reports may have incomplete information.

Do you take Gemcitabine and Effexor?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously